Orange Book (FDA Approved Drug Products)

The Orange Book is the FDA publication officially titled "Approved Drug Products with Therapeutic Equivalence Evaluations" that lists approved drug products within its scope and therapeutic equivalence evaluations for approved multisource prescription products; substitution also depends on state law and the prescription.

Get personalized explanations
💡

Exam Tip

Orange Book ratings inform substitution; state law and the prescription still apply. A = FDA therapeutic equivalence within the applicable group; B = not currently established. Match numbered AB groups. BC = extended-release; BN = aerosol-nebulizer systems; BP = potential bioequivalence issues.

What Is the Orange Book?

The Orange Book, officially titled "Approved Drug Products with Therapeutic Equivalence Evaluations," is published by the FDA and is the definitive reference for determining whether generic drugs are therapeutically equivalent to their brand-name counterparts. It is essential for pharmacy practice because TE ratings inform product selection, while state law, the prescription, and any applicable restrictions determine whether substitution is permitted.

Therapeutic Equivalence Ratings

RatingMeaningCan Substitute?
A-rated (e.g., AB, AN, AP)FDA considers products therapeutically equivalent within the applicable groupPotentially; follow state law and prescription restrictions
B-rated (e.g., BN, BP, BS)FDA does not currently consider the products therapeutically equivalentDo not assume automatic substitution; consult the pharmacist

Common A-Ratings

CodeDrug Type
AAConventional dosage forms without known or suspected bioequivalence problems
ABActual or potential bioequivalence issues resolved with adequate evidence; match numbered groups such as AB1/AB2
ANSolutions and powders for aerosolization in general-use delivery systems
AOInjectable oil solutions
APInjectable aqueous solutions
ATTopical products

Common B-Ratings

CodeReason
BCExtended-release products lacking adequate equivalence evidence
BNProducts in aerosol-nebulizer drug delivery systems
BDActive ingredients/dosage forms with documented bioequivalence problems
BPActive ingredients/dosage forms with potential bioequivalence problems
BSDrug products with known deficiencies
BXInsufficient data for equivalence determination

How the Orange Book Is Used

UserApplication
PharmacistsDetermine if generic substitution is appropriate
Pharmacy techniciansIdentify correct generic alternatives during dispensing
Insurance/PBMsSet formulary and reimbursement policies
ManufacturersIdentify opportunities for generic drug development

Orange Book vs. Purple Book

FeatureOrange BookPurple Book
CoversSmall-molecule drugsBiological products
Equivalence termTherapeutic equivalenceBiosimilarity/interchangeability
Rating systemA/B ratingsBiosimilar/interchangeable designation

Exam Alert

The Orange Book falls under the Medications domain and Order Entry and Processing domain on the PTCE. Know that A ratings establish FDA therapeutic equivalence within the relevant group; they do not override state substitution law or a prescriber restriction. AB1 and AB2 are different groups. The Orange Book is the FDA's reference for generic substitution decisions.

Study This Term In

Related Terms

Where shall we go next?

Your AI study companion · 10 free interactions a day

Stay Updated

Get free exam tips and study guides delivered to your inbox.

Free exam tips & study guides. Unsubscribe anytime.